These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7743473)

  • 21. Predominant p53 G-->A transition mutation and enhanced cell proliferation in uterine sarcomas of CBA mice treated with 1,2-dimethylhydrazine.
    Trukhanova LS; Hong HH; Sills RC; Bowser AD; Gaul B; Boorman GA; Turusov VS; Devereux TR; Dixon D
    Toxicol Pathol; 1998; 26(3):367-74. PubMed ID: 9608642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
    Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
    Kwon JS; Abrams J; Sugimoto A; Carey MS
    Int J Gynecol Cancer; 2008; 18(4):820-4. PubMed ID: 17892450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histologic characterization of uterine papillary serous adenocarcinoma.
    Miller B; Umpierre S; Tornos C; Burke T
    Gynecol Oncol; 1995 Mar; 56(3):425-9. PubMed ID: 7705679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study.
    Greggi S; Mangili G; Scaffa C; Scala F; Losito S; Iodice F; Pisano C; Montoli S; Viganò R; Pirozzi G; Giannarelli D
    Int J Gynecol Cancer; 2011 May; 21(4):661-7. PubMed ID: 21412164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 protein overexpression and gene mutation in mixed Müllerian tumors of the uterus.
    Soong R; Knowles S; Hammond IG; Michael C; Iacopetta BJ
    Cancer Detect Prev; 1999; 23(1):8-12. PubMed ID: 9892985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum.
    Muto MG; Welch WR; Mok SC; Bandera CA; Fishbaugh PM; Tsao SW; Lau CC; Goodman HM; Knapp RC; Berkowitz RS
    Cancer Res; 1995 Feb; 55(3):490-2. PubMed ID: 7834614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and characterization of a human cell line derived from a uterine papillary serous carcinoma with wild-type p53 function.
    Hashimoto H; Kojima A; Sudo T; Ohki N; Yamaguchi S; Mikami Y; Ito M; Nishimura R
    Hum Cell; 2008 Aug; 21(3):64-9. PubMed ID: 18667022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.
    Santin AD; Bellone S; Van Stedum S; Bushen W; Palmieri M; Siegel ER; De Las Casas LE; Roman JJ; Burnett A; Pecorelli S
    Cancer; 2005 Oct; 104(7):1391-7. PubMed ID: 16116605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine papillary serous carcinoma--the KK Hospital experience.
    Ho TH; Lim TL; Tan HS
    Ann Acad Med Singap; 1998 Sep; 27(5):640-4. PubMed ID: 9919332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival.
    Memarzadeh S; Holschneider CH; Bristow RE; Jones NL; Fu YS; Karlan BY; Berek JS; Farias-Eisner R
    Int J Gynecol Cancer; 2002; 12(5):454-8. PubMed ID: 12366662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
    Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E
    Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 mutations and overexpression in locally advanced breast cancers.
    Faille A; De Cremoux P; Extra JM; Linares G; Espie M; Bourstyn E; De Rocquancourt A; Giacchetti S; Marty M; Calvo F
    Br J Cancer; 1994 Jun; 69(6):1145-50. PubMed ID: 8198984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 protein overexpression in smooth muscle tumors of the uterus.
    Niemann TH; Raab SS; Lenel JC; Rodgers JR; Robinson RA
    Hum Pathol; 1995 Apr; 26(4):375-9. PubMed ID: 7705814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
    Khalifa MA; Mannel RS; Haraway SD; Walker J; Min KW
    Gynecol Oncol; 1994 Apr; 53(1):84-92. PubMed ID: 7909788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder.
    Gao JP; Uchida T; Wang C; Jiang SX; Matsumoto K; Satoh T; Minei S; Soh S; Kameya T; Baba S
    Int J Oncol; 2000 Mar; 16(3):469-75. PubMed ID: 10675477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma.
    Kowalski LD; Kanbour AI; Price FV; Finkelstein SD; Christopherson WA; Seski JC; Naus GJ; Burnham JA; Kanbour-Shakir A; Edwards RP
    Cancer; 1997 Apr; 79(8):1587-94. PubMed ID: 9118043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.